Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 32Active not recruiting 28Completed 20Terminated 8Not yet recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 360Neoplasms 255Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 183Lung Neoplasms 152Prostatic Neoplasms 151Carcinoma, Hepatocellular 128Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 84Neoplasm Metastasis 74Recurrence 71Uterine Cervical Neoplasms 69Rectal Neoplasms 68Stomach Neoplasms 65Ovarian Neoplasms 65Triple Negative Breast Neoplasms 60Squamous Cell Carcinoma of Head and Neck 57Head and Neck Neoplasms 54Glioblastoma 54Brain Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 50Endometrial Neoplasms 47Melanoma 44Esophageal Neoplasms 43Disease 43Colonic Neoplasms 42Hematologic Neoplasms 41Glioma 40

Interventions

Watchful Waiting 1Nivolumab 1Melphalan 1Ipilimumab 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Uveal Melanoma × 1 year × Clear all
NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Herlev Hospital

Phase 1 Not yet recruiting
15 enrolled
Dermatologic

Uveal Melanoma

NCT07338968 2026-01-14

CoMpass

Aura Biosciences

Not yet recruiting
100 enrolled
Dermatologic

Uveal Melanoma

NCT07183852 2025-09-19

GoTIL-01

Vastra Gotaland Region

Phase 1 Not yet recruiting
18 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡